Annual report pursuant to Section 13 and 15(d)

Document and Entity Information

v3.3.0.814
Document and Entity Information - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2015
Aug. 26, 2015
Dec. 31, 2014
Document and Entity Information [Abstract]      
Entity Registrant Name DelMar Pharmaceuticals, Inc.    
Entity Central Index Key 0001498382    
Amendment Flag true    
Amendment Description This Amendment No. 1 to Form 10-K for the year ended June 30, 2015, amends DelMar Pharmaceuticals, Inc.'s (the "Company") Annual Report on Form 10-K for the year ended June 30, 2015, which was originally filed with the Securities and Exchange Commission on September 3, 2015 (the "Original 10-K") This amendment is being filed solely to (i) restate the financial statements for a failure to properly account for the granting of warrants issued to designees of the placement agent under the Company's private placement that closed in January to March 2013 (and make corresponding changes to Risk Factors and the Management's Discussion and Analysis of Financial Condition and Results of Operations sections) and (ii) amend Item 9A (Controls and Procedures). Except with respect to (i) the financial statements and corresponding changes to Risk Factors and Management's Discussion and Analysis of Financial Condition and Results of Operations, and (ii) Item 9A (Controls and Procedures), the Original 10-K has not been amended, updated or otherwise modified.    
Current Fiscal Year End Date --06-30    
Document Type 10-K    
Document Period End Date Jun. 30, 2015    
Document Fiscal Year Focus 2015    
Document Fiscal Period Focus FY    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 22.8
Entity Common Stock, Shares Outstanding   39,477,556